Pure Global

High Sensitivity C-Reactive Protein CLIA Kit - India CDSCO Medical Device Registration

High Sensitivity C-Reactive Protein CLIA Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000078_fc5726d357dd63b5f80affa28346c286_e7ca90e9be3901d3cf9809a6550e4f95. This device is marketed under the brand name AFP+CEA+PSA. The license holder is Tosoh India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
High Sensitivity C-Reactive Protein CLIA Kit
UID: MFG/IVD/2021/000078_fc5726d357dd63b5f80affa28346c286_e7ca90e9be3901d3cf9809a6550e4f95

Brand Name

AFP+CEA+PSA

License Holder

Tosoh India Pvt. Ltd.

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

For the Quantitative Determination of CRP C-Reactive Protein concentration in Human Serum, Plasma or Whole Blood by a Microplate Enzyme Immunoassay, Chemiluminescence method

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing